As Republicans work to reform Medicaid, they must contend with questions about the appropriate financial support level and the grant structure of the program, according to Gail Wilensky, PhD, of Project HOPE.
As Republicans work to reform Medicaid, they must contend with questions about the appropriate financial support level and the grant structure of the program, according to Gail Wilensky, PhD, of Project HOPE.
Transcript (slightly modified)
Medicaid has been a huge point of contention within the Republican Party. Do you think something will give?
I think there are 2 big questions about Medicaid. One is the financial support level. Are we talking about trying to extract, going forward, large sums of money? Are we talking about very modestly slowing the spend rate that we’ve seen on Medicaid? And the second is what should the structure be. I have much more sympathy with the move to a per capita block grant with some outcome metrics as a requirement, provided that the baseline makes sense and the rate of increase is appropriate for the different populations affected.
The reason I believe that is that we have seen in the past couple of decades most of the new money that has come in through Medicaid has been federal money, and much of the supposedly state match has been creative financing that just moves money around and then gives it back to the state. It has indicated some serious questions about the viability and validity of a matching grant in Medicaid. I think that continues to exist.
So, the structure is one thing. It’s now our only open-ended entitlement program left in the United States. Medicare, because of the IPAB structure, actually has a limit in place. I think questioning that is one idea. It is having a base structure and a growth rate that is appropriate, that is a whole different level of debate. People unfortunately are mixing the two up.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Finding the Right Biomarker Is Key to the TIGIT Puzzle, Experts Say
May 12th 2025Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, align with recent bad news for this once-promising therapeutic target. But investigators involved in TIGIT studies say the problem is finding the right biomarker.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR
May 5th 2025KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, as highlighted at the 2025 meeting of the American Association for Cancer Research (AACR).
Read More